Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin

FEBS Lett. 2005 Feb 14;579(5):1143-8. doi: 10.1016/j.febslet.2004.12.085.

Abstract

Human islet amyloid polypeptide (hIAPP) forms amyloid deposits in non-insulin-dependent diabetes mellitus (NIDDM). Pre-fibrillar hIAPP oligomers (in contrast to monomeric IAPP or mature fibrils) increase membrane permeability, suggesting an important role in the disease. In the first structural study of membrane-associated hIAPP, lamellar neutron diffraction shows that oligomeric hIAPP inserts into phospholipid bilayers, and extends across the membrane. Rifampicin, which inhibits hIAPP-induced membrane permeabilisation in functional studies, prevents membrane insertion. In contrast, rat IAPP (84% identical to hIAPP, but non-amyloidogenic) does not insert into bilayers. Our findings are consistent with the hypothesis that membrane-active pre-fibrillar hIAPP oligomers insert into beta cell membranes in NIDDM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / chemistry*
  • Amyloid / metabolism*
  • Animals
  • Cell Membrane Permeability
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Islet Amyloid Polypeptide
  • Lipid Bilayers / chemistry
  • Lipid Bilayers / metabolism*
  • Molecular Structure
  • Neutron Diffraction
  • Peptides / chemistry*
  • Peptides / metabolism*
  • Phospholipids / chemistry
  • Phospholipids / metabolism
  • Rats
  • Rifampin / chemistry
  • Rifampin / pharmacology*
  • Water / chemistry

Substances

  • Amyloid
  • Islet Amyloid Polypeptide
  • Lipid Bilayers
  • Peptides
  • Phospholipids
  • Water
  • Rifampin